Immune to Cancer: The CRI Blog
-
Can Viruses Fight Cancer? What Tudriqev Means for Patients With Melanoma
The U.S. Food and Drug Administration’s (FDA) accelerated approval of Tudriqev marks FDA’s first new approval of… -
Meet the 2026 STARs: Aaron Whiteley, PhD
I’m a microbiologist who’s passionate about immune signaling. Meet Aaron Whiteley, PhD, an Assistant Professor in the… -
The Future Starts Here: Meet the 2025–2026 Postdoctoral Fellows
Tomorrow’s breakthroughs in cancer immunotherapy begin with today’s early-career scientists. By investing in promising researchers at the… -
Why Is Lung Cancer Rising in Nonsmokers?
For decades, lung cancer has been closely associated with smoking — and for good reason. Smoking remains… -
From Bold Ideas to Breakthroughs: Introducing CRI’s 2026 CLIP & Technology Impact Award Projects
What if the next advance in cancer immunotherapy starts with one bold idea? Every breakthrough begins with… -
What Patients Should Know About Sarcoma and Immunotherapy
Sarcoma is rare and complex. Immunotherapy isn’t yet an option for everyone — but it’s changing what’s… -
Into the Light: The Science of Sun Safety
Jump to Section: Your skin is the largest organ in your body — and one of the… -
A Promise Made, A Promise Kept: Meet the Inaugural CRI IGNITE Fellows
In October 2025, the Cancer Research Institute (CRI) announced the launch of our new funding program, the… -
Dr. Susumu Tonegawa was a True Pioneer Who Reshaped Modern Immunology
The Cancer Research Institute (CRI) mourns the passing of Susumu Tonegawa, PhD, Nobel laureate, pioneering molecular biologist,…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.